(
out of
137
reviews
)
Clinical Locations
Primary Location
Huntsman Cancer Institute - Cancer Hospital South
Radiation Oncology
1950 Circle of Hope
Salt Lake City
,
UT
84112
Board Certification
|
American Board of Radiology (Radiation Oncology)
|
Patient Rating
5.0
/5
( out of
137 reviews
)
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Radiation Oncology
-Assistant Professor |
|---|---|
| Board Certification |
American Board of Radiology (Radiation Oncology)
|
Education history
| Undergraduate | Major: Zoology; Minor: Chemistry - Weber State University, Ogden, UT | B.S. |
|---|---|---|
| Professional Medical | Medicine - Michigan State University College of Human Medicine, East Lansing, MI | M.D. |
| Internship | Internal Medicine - Beaumont Health, Oakwood Hospital, Dearborn, MI | Intern |
| Residency | Radiation Oncology - Yale School of Medicine, New Haven, CT | Resident |
| Research Fellow | National Clinician Scholars Program - Yale School of Medicine, New Haven, CT | Research Fellow |
| Chief Resident | Radiation Oncology - Yale School of Medicine, New Haven, CT | Chief Resident |
| Certification | Clinical Educator, Teaching and Learning Center - Yale School of Medicine, New Haven, CT | Certification |
Selected Publications
Journal Article
- Tward J, Lloyd S, Johnson S, Dechet C, Nei BO, Maughan B, Swami U, Gupta S, Sanchez A, Kokeny K, Agarwal (2025). A Phase 2 Trial of Radium(223) and Stereotactic Ablative Radiotherapy in Hormone-Naïve Men with Oligometastatic Prostate Cancer to Bone: The RadSABR study. International journal of radiation oncology, biology, physics,
- Fridman I, Smith C, Barrett A, Johnson S, Bhowmick A, Hayes S, Elston Lafata (2025). Navigating Disagreements on Health Information: How Patients With Cancer Perceive Health Care Providers' Approaches to Discussing Patient-Identified Information. JCO oncology practice, OP2400071.
- Parker ND, Johnson SB, King AJ, Amin TB, Swire-Thompson B, Zhang Z, Bylund C (2025). Assessing Cancer Patients' Exposure to Treatment Misinformation. Journal of cancer education,
- Huisman KM, Whitaker MK, Johnson SB, Walker G (2025). Paging Dr. Google: Characterizing Direct-to-Consumer Digital Advertisements From Oncology Treatment Centers. Cureus, 17(3), e80994.
- Lee H, Shen J, Fadlullah MZ, Neibling A, Hanson C, Ampaw E, Lin T, Larsen M, Lloyd J, Maughan BL, Swami U, Gupta S, Tward J, Johnson SB, O'Neil B, Schmidt B, Dechet CB, Haaland B, Wang L, Tan AC, Kohli (2025). Circulatory prostate cancer proteome landscapes and prognostic biomarkers in metastatic castrate resistant prostate cancer. Clinical proteomics, 22(1), 13.
- Turner CA, King AJ, Tovar I, Millar MM, Codden RR, Guo JW, Johnson S, Kirchhoff AC, Raber M, Sheng X, Kepka D, Warner E (2025). Evaluating the Feasibility of Web-Monitoring Methodology for Measuring Exposure to Online Cancer Misinformation. JMIR cancer, 11, e65887.
- Fridman I, Johnson SB, Derry-Vick H (2025). When Limited Clinical Time With Patients Meets Unlimited Online Information. JMIR cancer, 11, e79031.
- Howell JN, Wilkes J, Maughan NM, Patel RB, Barney B, Taunk NK, Escorcia FE, Johnson SB, Boothe (2025). Industry Sponsorship and Disease Site Focus in Therapeutic Radiopharmaceutical Clinical Trials Over the Past Decade. International journal of radiation oncology, biology, physics,
- Hutten RJ, Odei B, Johnson SB, Tward J (2024). Validation of the Combined Clinical Cell-Cycle Risk Score to Prognosticate Early Prostate Cancer Metastasis From Biopsy Specimens and Comparison With Other Routinely Used Risk Classifiers. JCO precision oncology, 8, e2300364.
- Bylund CL, Taylor G, Vasquez TS, Alpert J, Johnson SB, Le T, Paige SR, Close J, Markham M (2024). Talking with clinicians about online cancer information: a survey of cancer patients and surrogate information seekers. Supportive care in cancer, 32(6), 362.
- Mullis MD,Fisher CL,Johnson SB,Liu T,Amin TB,Rogers S,DeGruccio K,Bylund C (2024). Clinician-patient communication about cancer treatment misinformation: The Misinformation Response Model. PEC innovation, 5,
- Roach E,Hutten R,Johnson S,Suneja G,Tward J,Petereit D,Gaffney (2024). The impact of a positive COVID-19 test on timeliness of radiation in patients receiving brachytherapy. Brachytherapy, 23(3), 360-367.
- Swire-Thompson B, Kilgallen K, Dobbs M, Bodenger J, Wihbey J, Johnson (2024). Discrediting health disinformation sources: Advantages of highlighting low expertise. Journal of experimental psychology. General, 153(9), 2299-2313.
- Bylund CL, Mullis MD, Alpert J, Markham MJ, Onega T, Fisher CL, Johnson S (2023). Clinician Communication With Patients About Cancer Misinformation: A Qualitative Study. JCO oncology practice, 19(3), OP2200526.
- Johnson SB, King AJ, Warner EL, Aneja S, Kann BH, Bylund C (2023). Using ChatGPT to evaluate cancer myths and misconceptions: artificial intelligence and cancer information. JNCI cancer spectrum, 7(2),
- Johnson SB, Bylund C (2023). Identifying Cancer Treatment Misinformation and Strategies to Mitigate Its Effects With Improved Radiation Oncologist-Patient Communication. Practical radiation oncology,
- Peterson J, Wilson TF, Watt MH, Gruhl J, Davis S, Olsen J, Parsons MW, Kann BH, Swire-Thompson B, Fagerlin A, Warner EL, King AJ, Chino F, Johnson S (2023). International medical tourism of US cancer patients for alternative cancer treatments: Financial, demographic, and clinical profiles of online crowdfunding campaigns. Cancer Med, 12(7), 8871-8879.
- Hutten RJ,Weil CR,King AJ,Barney B,Bylund CL,Fagerlin A,Gaffney DK,Gill D,Scherer L,Suneja G,Tward JD,Warner EL,Werner TL,Whipple G,Evans J,Johnson S (2023). Multi-Institutional Analysis of Cancer Patient Exposure, Perceptions, and Trust in Information Sources Regarding Complementary and Alternative Medicine. JCO oncology practice, 19(11), 1000-1008.
- Johnson SB,King AJ,Warner EL,Aneja S,Kann BH,Bylund C (2023). Using ChatGPT to evaluate cancer myths and misconceptions: artificial intelligence and cancer information. JNCI cancer spectrum, 7(2),
- Fridman I,Johnson S,Elston Lafata (2023). Health Information and Misinformation: A Framework to Guide Research and Practice. JMIR medical education, 9,
- Fridman I, Johnson S, Elston Lafata (2023). Health Information and Misinformation: A Framework to Guide Research and Practice. JMIR medical education, 9, e38687.
- Parsons MW, Hutten RJ, Tward A, Khouri A, Peterson J, Morrell G, Lloyd S, Cannon DM, Johnson S (2022). The Effect of Maximum Tumor Diameter by MRI on Disease Control in Intermediate and High-risk Prostate Cancer Patients Treated With Brachytherapy Boost. Clinical genitourinary cancer, 20(1), e68-e74.
- Hutten RJ, Nelson G, Sarkar V, Johnson SB, Tao R, Hitchcock Y, Chan J, Schroeder J, Kokeny (2022). Feasibility and clinical utility of a workflow interfacing radiation oncology lung stereotactic body radiotherapy treatment planning and diagnostic radiology. Practical radiation oncology, 12(6), e512-e516.
- Seymour ZA, Daignault-Newton S, McLaughlin PW, Sandler H, Jackson W, Johnson SB, Miller D, Wei J, Sanda M, Hamstra D (2022). Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment. Clinical and translational radiation oncology, 36, 56-62.
- Hutten R, Khouri A, Parsons M, Tward A, Wilson T, Peterson J, Morrell G, Dechet C, O'Neil B, Schmidt B, Kokeny K, Lloyd S, Cannon D, Tward J, Sanchez A, Johnson (2022). The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer. Clinical genitourinary cancer, 20(6), e453-e459.
- Peterson J, Wilson T, Gruhl J, Davis S, Olsen J, Parsons M, Kann B, Fagerlin A, Watt M, Johnson (2022). Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study. JMIR cancer, 8(2), e34183.
- Parsons M, Lloyd S, Johnson S, Scaife C, Soares H, Kim R, Kim R, Garrido-Laguna I, Tao (2022). The Implications of Treatment Delays in Adjuvant Therapy for Resected Cholangiocarcinoma Patients. Journal of gastrointestinal cancer, 54(2), 492-500.
- Seymour ZA,Daignault-Newton S,McLaughlin PW,Sandler H,Jackson W,Johnson SB,Miller D,Wei J,Sanda M,Hamstra D (2022). Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment. Clinical and translational radiation oncology, 36, 56-62.
- Peterson J,Wilson T,Gruhl J,Davis S,Olsen J,Parsons M,Kann B,Fagerlin A,Watt M,Johnson (2022). Timing and Motivations for Alternative Cancer Therapy with Insights from a Crowdfunding Platform: Cross-sectional Mixed Methods Study. JMIR cancer, 8(2),
- Hutten R,Khouri A,Parsons M,Tward A,Wilson T,Peterson J,Morrell G,Dechet C,O'Neil B,Schmidt B,Kokeny K,Lloyd S,Cannon D,Tward J,Sanchez A,Johnson (2022). The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer. Clinical genitourinary cancer,
- Parsons M,Lloyd S,Johnson S,Scaife C,Soares H,Kim R,Kim R,Garrido-Laguna I,Tao (2022). The Implications of Treatment Delays in Adjuvant Therapy for Resected Cholangiocarcinoma Patients. Journal of gastrointestinal cancer,
- Weil CR,Parsons MJ,Hutten RJ,Lew FH,Johnson SB,Gaffney DK,Tao (2022). Patterns of care and outcomes of early stage I'II Hodgkin lymphoma treated with or without radiation therapy. Leukemia & lymphoma,
- Fenlon JB, Hutten RJ, Johnson SB, Hu B, Shah H, Stephens DM, Maity A, Gaffney DK, Tao (2022). Evaluating patterns of care for early-stage low-grade follicular lymphoma in the rituximab era. Leukemia & lymphoma, 64(2), 1-8.
- Peterson JS, Plana D, Bitterman DS, Johnson SB, Aerts HJWL, Kann B (2022). Growth in eligibility criteria content and failure to accrue among National Cancer Institute (NCI)-affiliated clinical trials. Cancer medicine,
- Parsons M, Lloyd S, Johnson S, Scaife C, Varghese T, Glasgow R, Garrido-Laguna I, Tao R (2021). Refusal of Local Therapy in Esophageal Cancer and Impact on Overall Survival. Ann Surg Oncol, 28(2), 663-675.
- Miccio JA, Talcott WJ, Jairam V, Park HS, Yu JB, Leapman MS, Johnson SB, King MT, Nguyen PL, Kann BH (2021). Quantifying treatment selection bias effect on survival in comparative effectiveness research: findings from low-risk prostate cancer patients. Prostate Cancer Prostatic Dis, 24(2), 414-422.
- Hutten RJ, Parsons MW, Weil CR, Tward JD, Lloyd S, Sanchez A, Lester-Coll N, Johnson S (2021). Temporal Trends and Predictors in Diagnosing Pathologic Node-Positive Prostate Cancer in Clinically Node-Negative Patients. Clinical genitourinary cancer, 19(6), e360-e366.
- Johnson SB, Parsons M, Dorff T, Moran MS, Ward JH, Cohen SA, Akerley W, Bauman J, Hubbard J, Spratt DE, Bylund CL, Swire-Thompson B, Onega T, Scherer LD, Tward J, Fagerlin (2021). Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief Report. Journal of the National Cancer Institute, 114(7), 1036-1039.
- Hutten RJ, Weil CR, Tward JD, Lloyd S, Johnson S (2021). Patterns of Care and Treatment Outcomes in Locoregional Squamous Cell Carcinoma of the Prostate. European urology open science, 23, 30-33.
- Joseph Anthony Miccio, MD; Andrew Barsky, MD; Sarah Gao, MD; Vivek Verma, MD; Sonal S. Noticewala, MD, MAS; Vikram Jairam, MD; Skyler B. Johnson, MD; James B. Yu, MD, MHS; James E. Hansen, MD; Sanjay Aneja, MD; Yi An, MD; Roy H. Decker, MD, PhD; S. Bulent Omay, MD; Jing Li, MD, PhD; Goldie A. Kurtz, MD; Michelle Alonso-Basanta, MD, PhD; John Y.K. Lee, MD; Veronica Chiang, MD; Henry S. Park, MD, MPH (2020). Multi-Institutional Retrospective Review of Stereotactic Radiosurgery for Brain Metastasis in Patients with Small Cell Lung Cancer Without Prior Brain-Directed Radiotherapy. J Neurooncol.
- Cecchini M, Miccio JA, Pahade J, Lacy J, Salem RR, Johnson SB, Blakaj A, Stein S, Kortmansky JS, Johung KL (2020). A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic Cancer. Pancreas, 49(7), 904-911.
- Benjamin H. Kann, MD, Skyler B. Johnson, MD, Hugo J.W.L. Aerts, PhD, Raymond H. Mak, MD, Paul L. Nguyen, M (2020). Changes in Length and Complexity of Clinical Practice Guidelines in Oncology, 1996-2019. JAMA network open,
- Miccio JA, Barsky A, Gao S, Verma V, Noticewala SS, Jairam V, Johnson SB, Yu JB, Hansen JE, Aneja S, An Y, Decker RH, Bulent Omay S, Li J, Kurtz GA, Alonso-Basanta M, Lee JYK, Chiang VL, Park H (2020). Multi-institutional retrospective review of stereotactic radiosurgery for brain metastasis in patients with small cell lung cancer without prior brain-directed radiotherapy. Journal of radiosurgery and SBRT, 7(1), 19-27.
- Miccio JA,Barsky A,Gao S,Verma V,Noticewala SS,Jairam V,Johnson SB,Yu JB,Hansen JE,Aneja S,An Y,Decker RH,Omay SB,Li J,Kurtz GA,Alonso-Basanta M,Lee JYK,Chiang VL,Park H (2020). Multi-institutional retrospective review of stereotactic radiosurgery for brain metastasis in patients with small-cell lung cancer without prior brain-directed radiotherapy. Journal of radiosurgery and SBRT, 7(1), 19-27.
- Loganadane G, Kann BH, Park HS, Johnson SB, Mehra S, Judson BL, Bhatia A, Belkacemi Y, Yarbrough WG, Burtness B, Husain ZA (2019). Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy. Anticancer Res, 39(9), 4885-4890.
- Johnson SB, Hung J, Kapadia N, Oh KS, Kim M, Hamstra DA (2019). Spinal Growth Patterns After Craniospinal Irradiation in Children With Medulloblastoma. Pract Radiat Oncol, 9(1), e22-e28.
- Kole AJ, Park HS, Johnson SB, Kelly JR, Moran MS, Patel AA (2019). Overall survival is improved when DCIS accompanies invasive breast cancer. Sci Rep, 9(1), 9934.
- Johnson SB, Gross CP, Yu J (2019). Methodology Flaws and Implications of a Complementary Medicine Study-In Reply. JAMA oncology, 5(3), 433.
- Johnson S,Park H,Gross C,Yu (2019). Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival among Patients with Curable Cancers. Obstetrical & gynecological survey, 74(4), 217-219.
- Johnson SB, Park HS, Gross CP, Yu JB (2018). Use of Alternative Medicine for Cancer and Its Impact on Survival. J Natl Cancer Inst, 110(1).
- Johnson SB, Yu JB (2018). Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer. Curr Oncol Rep, 20(9), 66.
- Johnson SB, Decker RH (2018). Prophylactic Cranial Irradiation Versus Surveillance: Physician Bias and Patient-centered Decision-making. Clin Lung Cancer, 19(6), 464-466.
- Johnson SB, Park HS, Gross CP, Yu J (2018). Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers. JAMA oncology, 4(10), 1375-1381.
- Johnson SB, Lester-Coll NH, Kelly JR, Kann BH, Yu JB, Nath SK (2017). Brachytherapy Boost Utilization and Survival in Unfavorable-risk Prostate Cancer. Eur Urol, 72(5), 738-744.
- Lester-Coll NH, Johnson S, Magnuson WJ, Goldhaber SZ, Sher DJ, D'Amico AV, Yu JB (2017). Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer.LID - 10.1093/jnci/djw281 [doi]. J Natl Cancer Inst, 109(6).
- Kann BH, Park HS, Johnson SB, Chiang VL, Yu JB (2017). Radiosurgery for Brain Metastases: Changing Practice Patterns and Disparities in the United States. J Natl Compr Canc Netw, 15(12), 1494-1502.
- Jackson WC, Schipper MJ, Johnson SB, Foster C, Li D, Sandler HM, Palapattu GS, Hamstra DA, Feng FY (2016). Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol, 69(1), 50-7.
- Johnson SB, Soulos PR, Shafman TD, Mantz CA, Dosoretz AP, Ross R, Finkelstein SE, Collins SP, Suy S, Brower JV, Ritter MA, King CR, Kupelian PA, Horwitz EM, Pollack A, Abramowitz MC, Hallman MA, Faria S, Gross CP, Yu JB (2016). Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer. Radiother Oncol, 121(2), 294-298.
- Feng FY, Zhang Y, Kothari V, Evans JR, Jackson WC, Chen W, Johnson SB, Luczak C, Wang S, Hamstra DA (2016). MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner. Neoplasia, 18(4), 213-22.
- Johnson SB, Jackson WC, Murgic J, Feng FY, Hamstra DA (2015). Time to Nadir PSA: Of Popes and PSA--The Immortality Bias. Am J Clin Oncol, 38(5), 465-71.
- Jackson WC, Johnson SB, Feng FY, Hamstra DA (2015 Aug). Salvage radiation therapy improves metastasis-free survival for clinically aggressive and indolent prostate cancer recurrences after radical prostatectomy. Am J Clin Oncol, 38(4), 367-72.
- Hamstra DA, Johnson SB, Daignault S, Zikmund-Fisher BJ, Taylor JM, Larkin K, Wood A, Fagerlin A (2015 Jan). The impact of numeracy on verbatim knowledge of the longitudinal risk for prostate cancer recurrence following radiation therapy. Med Decis Making, 35(1), 27-36.
- Stenmark MH, Conlon AS, Johnson S, Daignault S, Litzenberg D, Marsh R, Ritter T, Vance S, Kazzi N, Feng FY, Sandler H, Sanda MG, Hamstra DA (2014). Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer. Radiother Oncol, 110(2), 291-7.
- Johnson SB, Zhou J, Jolly S, Guo B, Young L, Prisciandaro JI (2014 May-Jun). The dosimetric impact of single, dual, and triple tandem applicators in the treatment of intact uterine cancer. Brachytherapy, 13(3), 268-74.
- Foster CC, Jackson WC, Foster BC, Johnson SB, Feng FY, Hamstra DA (2014). Less advanced disease at initiation of salvage androgen deprivation therapy is associated with decreased mortality following biochemical failure post-salvage radiation therapy. Radiat Oncol, 9, 245.
- Jackson WC, Johnson SB, Foster B, Foster C, Li D, Song Y, Vainshtein J, Zhou J, Hamstra DA, Feng FY (2014). Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following salvage radiation therapy. Pract Radiat Oncol, 4(2), 99-107.
- Johnson S, Jackson W, Speers C, Feng F, Hamstra D (2014). A comprehensive assessment of the prognostic utility of the Stephenson nomogram for salvage radiation therapy postprostatectomy. Pract Radiat Oncol, 4(6), 422-9.
- Jackson W, Hamstra DA, Johnson S, Zhou J, Foster B, Foster C, Li D, Song Y, Palapattu GS, Kunju LP, Mehra R, Feng FY (2013). Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy. Cancer, 119(18), 3287-94.
- Johnson S, Jackson W, Li D, Song Y, Foster C, Foster B, Zhou J, Vainshtein J, Feng F, Hamstra D (2013). The interval to biochemical failure is prognostic for metastasis, prostate cancer-specific mortality, and overall mortality after salvage radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys, 86(3), 554-61.
- Hamstra DA, Stenmark MH, Ritter T, Litzenberg D, Jackson W, Johnson S, Albrecht-Unger L, Donaghy A, Phelps L, Blas K, Halverson S, Marsh R, Olson K, Feng FY (2013). Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys, 85(5), 1246-53.
- Johnson SB, Hamstra DA, Jackson WC, Zhou J, Foster B, Foster C, Song Y, Li D, Palapattu GS, Kunju L, Mehra R, Sandler H, Feng FY (2013 Oct 1). Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer. Int J Radiat Oncol Biol Phys, 87(2), 275-81.
- Jackson WC, Johnson SB, Li D, Foster C, Foster B, Song Y, Schipper M, Shilkrut M, Sandler HM, Morgan TM, Palapattu GS, Hamstra DA, Feng FY (2013 Jul 8). A prostate-specific antigen doubling time of 6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy. Radiat Oncol, 8, 170.
Review
- Swire-Thompson B,Johnson (2024). Cancer: A model topic for misinformation researchers. Current opinion in psychology, 56,
- Ford KL,Orsso CE,Kiss N,Johnson SB,Purcell SA,Gagnon A,Laviano A,Prado C (2022). Dietary choices after a cancer diagnosis: A narrative review. Nutrition (Burbank, Los Angeles County, Calif.), 103-104, 111838.
Book Chapter
- Johnson SB, Decker R (2017). Radiation Therapy. 157.
- Johnson SB, Damast S, Young (2016). Cervical Cancer.
Case Report
- Johnson SB, Prisciandaro JI, Zhou J, Hadley SW, Reynolds RK, Jolly S (2014). Primary peritoneal clear cell carcinoma treated with IMRT and interstitial HDR brachytherapy: a case report. J Appl Clin Med Phys, 15(1), 4520.
Editorial
- Peterson JS, Swire-Thompson B, Johnson SB (2020). What is the alternative? Responding strategically to cancer misinformation. Future Oncol, 16(25), 1883-1888.
- Johnson SB, Decker RH (Accepted). Prophylactic Cranial Irradiation Versus Surveillance:: Physician Bias in Prophylactic Cranial Irradiation (PCI) Decision Making-Opportunity for a Patient Decision Aid. Clin Lung Cancer,
Letter
- Hutten RJ,Weil CR,Tward JD,Lloyd S,Johnson S (2021). Patterns of Care and Treatment Outcomes in Locoregional Squamous Cell Carcinoma of the Prostate. European urology open science, 23, 30-33.
A very good doctor.
Dr. Johnson and his team are amazing. Thank you all for everything you do.
Highly recommend Dr Johnson and staff
Great Doctor. Listens to my concerns. Included me in the decisions for my health care.
He is great. Very knowledgeable and friendly and approachable.
Dr Johnson is a great Doctor
Dr. Johnson is the consummate professional. In addition to his medical background, Dr. Johnson has a very approachable personality that conveys concern for the patient.
Skyler is great. Good communicator and listener.
Always professional and to the point
He is a credit to the care shown by him a assocated staff and is a very thoughtful in dealing with me as a patient. He is the reason I chose to have the radiation treatment for my prostate cancer done at the Farmington, Utah location.
Great bedside manner. Very caring
knowledable,good demeanor, answers questions
Dr Johnson really cares about me and explained everything thing so that I understood what my options were. I highly recommend to anyone with prostrate issues, he's the best.
Very , Very Professional
Skyler B Johnson is a very good doctor and is always helpful and explains everything as he goes
Dr. Johnson in my opinion is the most concerned, understanding and personable doctors in his field. I've met a few while assisting my brother through his journey with liver cancer.
Very professional
I would definitely recommend Dr. Johnson for your health care. He has been very professional yet caring!
Dr. Johnson is an excellent and through doctor and very pleasant as well
I have been very pleased about the treatment and insight provided by Dr. Johnson
Dr. Johnson and his resident Dr. Jackson Howell were very clear and informative about my treatment options, risks and side effects.
I appreciate his expertise and compassion in dealing with me.
Awesome, well prepared, spoke plainly, listened, friendly
Excellent bedside manner
You feel comfortable talking with him. He makes the time for you.
Dr. Johnson is a great doctor who is personable and honest about the future of our care! He is understanding and explains everything clearly. He is the best!
Dr. Johnson is very kind and takes the time to find out how I'm doing and offer suggestions.
Dr Johnson is a very knowledgeable Dr. he takes his time to make sure you understand everything that is being done and makes sure all of your questions are answered.
Very professional and explained the procedure so I could understand.
Dr. Johnson's care is second-to-none! This good man has always taken good care of me and has been willing to listen and research suggestions. I trust him 100% with my health!
Dr. Johnson is the best!
He's just a very nice guy. He knows what he's talking about
Very professional and understanding of my needs.
Dr. Johnson was professional in explaining my issue, but did so in a way that was forthright but understanding of my concerns.
Couldn't ask for more sincere, earnest interest in providing the best possible care for my unique situation.
Dr. Johnson patiently answered all my questions and was on time !
great doctor very knowledgeable very great to work with
I fully trust him as a doctor
Felt as though he had time for me and answered all my questions and concerns
This is a five-star highly trained medical professional dealing with the most difficult cancer cases and I can attest that he cares not only about the individual but about getting the highest treatment options available per patient. A kind and naughty professional cancer treatment doctor, you will never find, except at this exceptional Cancer institute treatment center. How blessed and fortunate I was to be under Dr. Johnson's care. My prognosis looks very good thanks to him and his staff. Truly a 10 star professional!
Dr. Johnson is a dedicated researcher, practitioner and important citizen of the Huntsman Cancer Institute team. It's a privilege to receive care from such a powerful program.
Dr Johnson was extremely knowledgeable, professional, caring, courteous and helped answer all of our questions. We felt very cared for. Thank you so much!
Definitely one of the best doctors I've ever had
Since my first consultation, through my radiation treatments and on to follow-up care, Dr. Johnson and the entire team has been exceptional. The outcome of my care has been everything I hoped it would be and I am beyond grateful that I had access to U of U, Huntsman and the entire team.
Dr. Skyler Johnson has been my doctor since I began my fight against prostate cancer. He has given me confidence that we can control and possibly stop my cancer progression. He has always been positive and professional in his approach to solving my cancer problem. I highly recommend him.
Super nice Dr. He really cares about you and your conditions.
I really like him. He is a great doctor and great with me
He was very informative. Not arrogant or pushy. I really liked his bedside manner. I would highly recommend him to any cancer patient!
Dr. Johnson is the very best. Has the best knowledge of how to treat and care for me. But allows me to be in control of the decisions made regarding my treatment. I would not want any other physician overseeing my treatment and care
Great Doctor for any cancer patients to have.I am very satisfied with the service of Doctor Johnson
Dr Johnson was very caring and explained what was to be expected and why.
At this point I would truly recommend Dr. Johnson to others. He took the time to explain, to listen, and to answer questions. My wife and son were also very impressed.
I would give Dr. Johnson 10 Stars for his pleasant demeanor, for his extensive knowledge and for his genuine concern for my well-being.
Too bad Skyler isn't a general practitioner - I'd go to him exclusively.
Great physician with great bedside manner. Very knowledgeable.
Dr Johnson is knowledgeable professional!
If you ever have a cancer problem, go and see Dr Johnson ¿ He'll do his best to try and cure you (as he did me). I've been cancer free for 2 years. He's kind, knowledgeable, and caring. He's the BEST !!!
Dr. Johnson is the consummate professional and is very kind and considerate. He is friendly and always up to date and knowledgeable about my particular situation.
Very professional , friendly and kind person
We highly recommend Dr. Skyler Jonson.
He is caring and knowlegable.
Very caring and concerned about your medical issues. Thoroughly explained any necessary treatment and the outcome of testings. Listening to your concerns was Paramount. Very engaging
Dr. Johnson and his staff are the best. They are so knowledgeable and show much compassion.
DR. Johnson is very impressive and attentive. After all I am trusting my life to him.
I have been recommending Dr. Skyler Johnson to others, and to the Huntsman Cancer Institute.
A wonderful, caring MD. I really liked him.
Definitely consider Dr. Johnson but consider all your options- Radiation was the best option for me and Dr Johnson is very good¿.
very friendly explained things so easy to understand was very pleased with everyone
I feel like I am in good hands with Dr Johnson.
Exceptional! I never felt talked down to and felt my questions and concerns were taken seriously. Dr Johnson has a great personality and excellent ¿bedside manner¿, he really made me feel at ease.
I could not be more pleased with the level of care, recommended treatment, outcome, and overall concern Dr. Johnson has provided over the past year. He and his team are to be commended....seems rare to me that medical staff in general has the time and more accurately takes the time to talk through all aspects of diagnosis, treatment, challenges, concerns and prognosis. I have never left an appointment feeling as though I still had questions to ask or needed further clarification. Truly exceptional care!
Dr. Johnson and staff are wonderful people
Excellent care, took time to explain in detail the procedures that were gong to be done. Very caring and personable. I am very confident in his diagnosis and treatment.
Very personable, listens to me.
I really like Dr Johnson, i felt we were friends from our first visit. He came in the exam room sat on the exam bed and visited with my wife and I and explained what they could do for me and explained it in a kind way for us to understand . Him coming in and sitting on the bed made me relaxed , it was a casual friendly visit, coming in to the hospital you usually are stressed but i haven't been around him. I also like that he remembers things about you , like he asked about my fishing trip to alaska . I also feel he cares about me when he walks u out the the doorway of his dept in the hospital . I have never had a doctor do that . Cool guy !!!
Dr. Johnson has always listened to me and my concerns. Dt. Johnson has always taken my feelings, concerns and thoughts into consideration when recommending and following through with any treatment or course of action. I trust Dr. Johnson to give me the information I need that enable me to make informed decisions about my care. While Dr. Johnson may not always agree with my decisions, he respects my decisions and will provide the best treatment available to me based on my wishes.
His personality with patients is wonderful. His personality is as good as his knowledge.
Dr. Johnson was very thorough in his explanation of the radiation procedure, and the side effects.
That when he talked with us, he talked right up front told us what he thought and how he felt we were doing and we are very happy that we did what he suggested year a go. He is a good doctor.
I have the greatest confidence in Dr. Johnson's expertise, knowledge, and commitment to his patients and research.
Hes a very excellent doctor very nice person.When he meets with u he makes u feel like there is nothing to worry about n that is very important to the patient
Knowledgeable, caring, friendly
He gave me an idea of what to expect in laymans terms.
Excellent listener and was able to answer all of my questions on three test results that were unexplained by any of the doctors responsible for requesting the MRI,Fusion Biopsy and PET scan.
He has been super with my treatment.
I didn't see Dr. Johnson...
As hard as it was at the time, it would have been so much worse if Dr. Johnson and his staff (Emily) hadn't been there to help me. There is no way to adequately thank them.
He seemed concerned about the best-case for my age
Dr Johnson presented himself as a caring and compassionate physician.
Very understanding and explained the procedure that I was going to have.
He is a wonderful doctor
An awesome doctor!
I had a great experience with Skyler Johnson and would recommend him for anyone that would need his services!!!
Very friendly, professional and pleasant to work with.
Outstanding individual
He treats you like a person, not just a patient. He took the time to explain to me and my wife what was going on and what will happen during radiation. The best part was his goal, to help get me better. I loved the positive attitude towards that. It helped me to feel better.
I feel he genuinely cares about choosing a treatment program that offers the best outcome for me.
What I said seemed to matter. He made suggestions and had done the homework on my case. I felt attended to.
Our care plan for treatment was individualized with a focus on a belief that life is worth fighting for. Second opinions from a caring team offered a healthier approach to improving my personal results.
I am very happy with this doctor. I trust him very much
Every step of the way, Dr. Johnson spent meaningful time explaining my options. He explained all of the procedures that I would undergo as part of my radiation treatment. I was able to make informed decisions. And Dr. Johnson has a good sense of humor.
Dr. Johnson has shown the most compassion, care and understanding toward me. From consultation, to diagnosis, to treatment, and follow up. Dr. Johnson has answers EVERY question and concern I have had, regardless of how minor it may have seemed to him. Dr. Johnson hasten honest and direct with me in all aspects, giving me the information I wanted and needed. Dr. Johnson allowed me to make decisions on my care after providing all necessary information to me as requested and needed to make my own decisions. I could not have asked for, or want any other Radiation Oncologist overseeing my care.
As stated previously, Dr. Johnson and the entire care team exceeded every expectation I had. I felt like they treated me (and my wife) as though we were family. One wordexceptional!
Dr. Johnson was sensitive to my concerns and his experience allowed him to guide me through the entire treatment process! He is warm, friendly, and VERY Professional!
I am impressed by Dr. Johnson's depth of knowledge about prostate cancer. I trust him to prescribe the very best treatment for me.
He spent all the time required to answer my questions and alleviate my concern.
He was great- very kind and clear!
The staff and Dr. Johnson were courteous and professional and listened to our case in a genuine way. They gave us information and suggestions that were assuring as we face a serious situation in our family. Thanks to them we feel like we are moving forward.
I have the utmost confidence in Dr. Johnson
Dr Johnson is great. I feel fortunate to have him taking care of me.
Dr. Johnson explains my treatment in a way that is easy to understand, given the complexity of the subject. And he spends meaningful time with me doing so
He is simply tremendous! Great doctor
Dr Johnson spends a lot of time with you during treatment to make sure that you are comfortable.
I am confident that Dr. Johnson is very well qualified, very knowledgeable and skilled and has my best interests in mind
I really like Dr. Johnson. I feel he is the consummate professional and very caring about his patients. I have full confidence in his recommendations and treatment.
Very knowledgeable and patient oriented
Just met with him once but he was very thorough and knowledgeable
Very knowledgeable, understanding and took whatever time necessary to answer questions and address concerns
Dr. Johnson is caring and attentive to my needs as a patient. I always feel that my best interest is always the priority.
Very pleased to be working with Dr. Johnson.
He is the best
Dr. Johnson listened to my concerns and was very understanding and willing to work out my logistics situation.
He is OUTSTANDING !! A great doctor. He was able to kill the cancer cells that had invaded my prostate. Hes kind and had a great rapport with patients. Hes knowledgeable, concerned, and very friendly.
Cancer is not easy to explain and treatment options are not easy to explain but Dr. Johnson did an exceptional job. Also so grateful for Emily, she's amazing.
He was very informed about my issues and helpful to answer all my questions. I never felt rushed and I appreciated his willingness to answer tough questions about other treatment options outside his treatment plan
Precise and compassionate.
This is a stunning doctor who inspired huge confidence with me at a time when I was hit with hard and sometimes confusing choices.
lt was probably my fault for not explaining what I wanted more clearly. At the time it was probably because I did not clearly understand what I wanted.
Great experience. Dr. Johnson is very knowledgeable and professional. He gave me a treatment update based on a very recent prostate cancer conference. It's reassuring to know that he keeps current with developments in his field. I am confident that he is well qualified to care for me.
Professional and compassionate doctor, providing extended period of time to answer all my questions. Very impressive.
The doctor was very courteous and competent.
Very comfortable to consult with
Dr Johnson cares people wanting to be direct and very informative. He cares about me as a person.
He was patient . Took time to answer all of your questions. Listen to all your concerns. And explain your treatment plan quite well.
Dr Johnson had a way of making my wife and I feel very comfortable during our initial consultation. Questions were answered, needs were met, and we left feeling optimistic about the journey I have ahead.